VolitionRx Limited Investment Building and Building Improvements
VolitionRx Limited (VNRX) had Investment Building and Building Improvements of EUR 7.00 million as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Balance Sheet › Assets
us-gaap:InvestmentBuildingAndBuildingImprovements · last filed 2018-03-01
- 2017-12-31: Investment Building and Building Improvements 7.00M EUR.
| Period end | Investment Building and Building Improvements |
|---|---|
| 2017-12-31 | 7.00M EUR 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |